Business

5N Plus Announces Long Term Supply Agreement with Samsung for Engineered Substrates for the Next Generation of Medical Imaging Systems

5N Plus Announces Long Term Supply Agreement with Samsung for Engineered Substrates for t...

article5n Plus Inc.October 19, 20215/company/5n-plus-inc/news/5n-plus-announces-long-term-supply-agreement-with-samsung-for-engineered-substrates-for-the-next-generation-of-medical-imaging-systems
5N Plus Announces Long Term Supply Agreement with Samsung for Engineered Substrates for the Next Generation of Medical Imaging Systems

About this update from 5n Plus Inc.

[{"type":"text","content":"\n \n \n \n 5N Plus Announces Long Term Supply Agreement with Samsung for Engineered Substrates for the Next Generation of Medical Imaging Systems\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n Multi-year joint development program has yielded disruptive X-ray imaging technology\n \n \n \n \n All amounts expressed in U.S. dollars.\n \n \n \n \n MONTREAL\n \n ,\n \n Oct. 19, 2021\n \n /CNW Telbec/ - 5N Plus Inc. (\"5N Plus\" or the \"Company\") (TSX: VNP), a leading global producer of specialty semiconductors and performance materials, today announced a long-term agreement with Samsung Electronics Co. (\"Samsung\") to supply engineered substrates based on II-VI semiconductor materials for the detector core of the next generation of medical imaging devices. The detector is based on Photon Counting Detector (\"PCD\") technology, and will be incorporated into computed tomography (\"CT\") by Samsung's subsidiary NeuroLogica Corp., located in\n \n Danvers, Massachusetts\n \n .\n \n \n \n Market driver for PCD technology\n \n \n The global market for medical imaging based on CT is estimated to over\n \n five billion dollars\n \n in revenue. The detector element comprises 5 to 10% of the cost associated with the device. Over 95% of the CT imaging devices produced today are non-PCD-based. The increased demand for enhanced diagnostics, radiation reduction and cost efficacy have made this market ripe for innovation. PCD technology is at the forefront of addressing the latent demands associated with this market. In recent years, the advancements in product and process technologies have delivered PCD-based imaging systems with superior image quality and reduced radiation levels not achievable with the current mainstream technology.\n \n \n \n Collaborative innovation delivering breakthrough technology\n \n \n Over the last several years, 5N Plus has been developing engineered substrates for high-performance detectors essential for applications in medical and security markets. These efforts have recentl...

More updates from 5n Plus Inc.